<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02387931</url>
  </required_header>
  <id_info>
    <org_study_id>P00007860</org_study_id>
    <nct_id>NCT02387931</nct_id>
  </id_info>
  <brief_title>Supplementation in Adolescent Girls With Endometriosis</brief_title>
  <acronym>SAGE</acronym>
  <official_title>SAGE: Supplementation in Adolescent Girls With Endometriosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Children’s Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether dietary supplementation with Vitamin D or
      Fish Oil can help to reduce physical and emotional symptoms in adolescent girls with
      endometriosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized controlled trial designed to evaluate the effect of dietary
      supplementation on endometriosis symptom remediation. Adolescent and young adults females
      aged 12 to 25 years with a surgically-confirmed diagnosis of endometriosis will be eligible
      for study participation. Subjects will be excluded if they have concurrent chronic illnesses
      that affect gastrointestinal absorption of nutrients (e.g., celiac disease, IBD, cystic
      fibrosis), a history of renal stones, are pregnant, or non-English speaking. Once consented,
      subjects will be randomized to one of 3 treatment assignments: 1) vitamin D3 2000 IU daily
      (n=30), 2) fish oil 1000 mg daily (n=30), 3) placebo (n=30) and will take these daily for 6
      months. Baseline nutrient intake from food and supplements will be assessed using the Food
      Frequency Questionnaire (FFQ). The 142 item survey assesses usual dietary intake during the
      past year. Validated rating scales including the visual analog scale (VAS), SF-36, and the
      World Endometriosis EPHect questionnaires will be used to measure pain and overall quality of
      life. The SF-36 measures 8 health concepts relevant across disease groups, including
      limitations to physical or social activities because of health problems, vitality, and
      general health perception. Patients will complete a full review of medication usage, past
      medical history, family history, and other lifestyle factors. Anthropometrics will be
      measured, and vital signs obtained. Measures will be repeated at 3-month intervals for a
      total of 6 months. Blood will be drawn at baseline, and at 6 months to measure levels of
      fatty acids, vitamin D, parathyroid hormone (PTH), and calcium.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endometriosis pain</measure>
    <time_frame>6 months</time_frame>
    <description>Measured by change in the score of the visual analog scale (VAS) from baseline to 6 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 months</time_frame>
    <description>Measured by change in SF-36 and EPHect questionnaires from baseline to 6 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain medication usage</measure>
    <time_frame>6 months</time_frame>
    <description>Measured via questionnaire of medication usage from baseline to 6 months.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">69</enrollment>
  <condition>Endometriosis</condition>
  <arm_group>
    <arm_group_label>Vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D3 2000 IU daily taken for 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fish Oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fish Oil 1000 mg daily for 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo taken daily for 6 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>Nature Made Vitamin D 2000IU, 1 softgel taken daily</description>
    <arm_group_label>Vitamin D</arm_group_label>
    <other_name>Nature Made Vitamin D 2000IU Liquid softgels</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fish Oil</intervention_name>
    <description>Nature Made ultra omega-3 mini fish oil 500mg, 2 soft gels taken daily</description>
    <arm_group_label>Fish Oil</arm_group_label>
    <other_name>Nature Made ultra omega-3 mini fish oil 500mg, 2 daily</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo capsule, 2 taken daily</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Placebo capsule</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female

          -  Age 12 years -25 years

          -  Previously surgically diagnosed at Boston Children's Hospital with endometriosis

          -  At least 6 weeks following laparoscopy

          -  Minimum pain score within the 4 weeks preceding study baseline

          -  Must be able to swallow an empty 00 gelatin capsule at baseline

          -  Must be willing to stop all vitamins and nutritional supplements during trial

        Exclusion Criteria:

          -  Concurrent chronic illnesses that affect gastrointestinal absorption of nutrients
             (e.g., celiac disease, IBD, cystic fibrosis)

          -  Vitamin D level of greater than or equal to 100 ng/ml at study baseline

          -  History of renal stones

          -  No access to text messages or email

          -  Pregnancy

          -  Non-English speaking
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stacey A Missmer, ScD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Reproductive Medicine, Brigham and Women's Hospital and Harvard Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 29, 2013</study_first_submitted>
  <study_first_submitted_qc>March 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2015</study_first_posted>
  <last_update_submitted>November 30, 2016</last_update_submitted>
  <last_update_submitted_qc>November 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children’s Hospital</investigator_affiliation>
    <investigator_full_name>Stacey Missmer</investigator_full_name>
    <investigator_title>Stacey Missmer, ScD</investigator_title>
  </responsible_party>
  <keyword>Adolescent</keyword>
  <keyword>Endometriosis</keyword>
  <keyword>Diet</keyword>
  <keyword>Nutrition</keyword>
  <keyword>Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

